Court Upholds Decision on Export Obligation Extension Request

The court dismissed the petition challenging the rejection of the request for reconsideration of the earlier decision by the PRC regarding the extension of the export obligation period for an Advance Authorization. The court upheld the PRC's decision, emphasizing that policy relaxation is discretionary and not a right, and found no material evidence of genuine hardship warranting further extension. The court ruled that the PRC's decision was in line with the guidelines of the Foreign Trade Policy, and the petitioner's reliance on previous cases was deemed misplaced.

---

---

Issues Involved:
1. Rejection of the petitioner's request for reconsideration of the PRC's earlier decision.
2. Denial of extension of the export obligation period for the Advance Authorization.
3. Petitioner's compliance with export obligations and related hardships.
4. Applicability of policy provisions and relaxation under the Foreign Trade Policy (FTP).

Issue-Wise Detailed Analysis:

1. Rejection of the petitioner's request for reconsideration of the PRC's earlier decision:
The petitioner challenged the PRC's decision from its meeting on 08.08.2017, which upheld its earlier decision from 19.07.2016, denying an extension of the export obligation period for Advance Authorization No. 0310696315 dated 28.05.2012. The PRC had extended the export obligation period from twelve months to eighteen months but rejected further extensions.

2. Denial of extension of the export obligation period for the Advance Authorization:
The petitioner, a merchant exporter of pharmaceutical products, imported Cycloserine USP under an Advance Authorization and exported it in nine tranches. Despite fulfilling the export obligation in terms of quantity and value, some shipments were made beyond the extended export obligation period. The Licensing Authority issued deficiency letters, and the PRC extended the period by six months, which the petitioner contested, seeking further extension.

3. Petitioner's compliance with export obligations and related hardships:
The petitioner argued that it faced genuine hardships due to policy changes by the Russian Government and that the DGFT should have granted relaxation under paragraph 2.5 of the FTP. The petitioner contended that it had imported drugs from a registered source, implying a thirty-six-month export obligation period, and cited a similar case (Mylan Laboratories Ltd.) where the PRC extended the period from eighteen to thirty-six months.

4. Applicability of policy provisions and relaxation under the Foreign Trade Policy (FTP):
The court rejected the petitioner's claim of a thirty-six-month export obligation period, noting that the petitioner had not raised this argument earlier and had sought extensions based on a twelve-month period. Paragraph 4.22 of the Handbook of Procedures specified a twelve-month period for drugs from the date of import. The court found no material evidence of genuine hardship warranting further extension and upheld the PRC's decision, emphasizing that policy relaxation is discretionary and not a right.

Judgment:
The court dismissed the petition, ruling that the PRC's decision was neither perverse nor arbitrary and adhered to the guidelines of paragraph 2.5 of the FTP. The petitioner's reliance on the Supreme Court decision in Macquarie Bank Limited was deemed misplaced, as export obligations are substantive conditions, not procedural matters. The court also found no relevant factual matrix in the Mylan Laboratories Ltd. case to support the petitioner's claim.

---